Your free online event invitation
YOUR FREE ONLINE EVENT INVITATION |
|
|
WHAT IS THE FUTURE OF LIFE SCIENCES? |
|
|
Join our panel of experts on Thursday 17th November, to discuss the challenges and opportunities for the biotech and pharmaceutical industries and the transformational changes that are now becoming possible. Our ability to develop, manufacture and distribute therapeutics has changed dramatically with covid, Brexit and the increasingly volatile geopolitical landscape. That has created numerous challenges for life sciences companies in the risks they face, in securing supply chains and in managing regulatory affairs. But periods of great change bring opportunities too as new products and approaches emerge and markets evolve. |
|
|
What the medium and long term opportunities are for this sector and how can you best capitalise on them? How can the opportunities and challenges for the life science industry best be managed in this post-pandemic world? - How does the increasingly volatile geopolitical landscape change the calculus for innovation?
|
|
|
OUR EXPERT PANEL INCLUDES… |
|
|
RICHARD TORBETT: CEO, ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY |
| ANUSHA FOY: HEAD OF LIFE SCIENCES BIOTECH REGULATORY SOLUTIONS PRACTICE, KPMG |
| ALAN MORRISON: VICE PRESIDENT OF REGULATORY AFFAIRS INTERNATIONAL, MSD |
| NIGEL BLACKBURN: DIRECTOR OF DRUG DEVELOPMENT, CANCER RESEARCH UK |
|
|
This email has been sent to submitpostforlive@gmail.com.
Unsubscribe from New Scientist Events emails |
Do not reply directly to this email. If you have an enquiry, please contact us using the relevant contact details listed here. |
Copyright © New Scientist Ltd
Registered Office: Northcliffe House, 2 Derry Street, London, W8 5TT
Registered in England. No.10644366
Australian mailing address: PO Box 2315, Strawberry Hills, NSW 2012, Australia
Registered in Australia. ABN 22 621 413 170
Privacy Policy | Terms & Conditions |
|
|
|
|
|
|
